Lundbeck Foundation portfolio company acquired for USD 230m

Vifor Pharma is acquiring biotech company Sanifit, which Lundbeckfonden Ventures has invested in since 2015.
Photo: PR / Vifor Pharma
Photo: PR / Vifor Pharma
by mikkel aabenhus hemmingsen, translated by catherine brett

Biotech company Sanifit is changing hands after Swiss company Vifor Pharma has made a deal to take over the firm.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading